Back to All Resources

Drugging Tissue Restricted E3 Ligases for TPD-based Precision Medicine

April 27, 2022

2nd Annual Ligase Targeting Drug Development Summit

Screen Shot 2022-04-25 at 9.43.28 AM
View Presentation
Area of Focus
Platform Targeted Protein Degradation
Programs
Other
Development Stage
Pre-clinical Data
Share
LinkedInXFacebookEmailCopy Link

You may also be interested in these resources

August 15, 2022
MQAtlas Creates a Deep, Accurate and Global E3 Expression Atlas Enabling Targeted Protein Degradation Based Precision Medicine
The 14th International Symposium on Mass Spectrometry in the Health and Life Sciences
View Resource
December 7, 2022
Proteomics enabling TPD Drug Discovery
TPD Assay Development and Screening Summit
View Resource